Santhera Pharmaceuticals
27 clinical trials · Sponsor
◉ Watch Santhera Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study on Safety and Effectiveness of Long-term Treatment With Vamorolone in Boys With Duchenne Muscular Dystrophy (NCT06713135) | Santhera Pharmaceuticals | 2024-11-10 |
| Evaluation of Vamorolone CYP3A4 Induction on Midazolam (a Sensitive CYP 3A4 Substrate) Pharmacokinetics (NCT06689527) | Santhera Pharmaceuticals | 2024-08-13 |
| Evaluation of Vamorolone Mineralocorticoid Receptor Antagonism in Healthy Subjects (NCT06649409) | Santhera Pharmaceuticals | 2024-06-05 |
| Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 in Patients With CF (NCT03748199) | Santhera Pharmaceuticals | 2018-11-08 |
| Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E) (NCT03603288) | Santhera Pharmaceuticals | 2018-07-04 |
Track Santhera Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.